These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33874979)

  • 1. Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma.
    Jou YC; Lin GL; Lin HY; Huang WH; Chuang YM; Lin RI; Chen PC; Wu SF; Shen CH; Chan MWY
    Cancer Cell Int; 2021 Apr; 21(1):226. PubMed ID: 33874979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.
    Yeh CM; Chen PC; Hsieh HY; Jou YC; Lin CT; Tsai MH; Huang WY; Wang YT; Lin RI; Chen SS; Tung CL; Wu SF; Chang DC; Shen CH; Hsu CD; Chan MW
    Oncotarget; 2015 Oct; 6(30):29555-72. PubMed ID: 26320192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyproheptadine exhibits antitumor activity in urothelial carcinoma cells by targeting GSK3β to suppress mTOR and β-catenin signaling pathways.
    Hsieh HY; Shen CH; Lin RI; Feng YM; Huang SY; Wang YH; Wu SF; Hsu CD; Chan MW
    Cancer Lett; 2016 Jan; 370(1):56-65. PubMed ID: 26454215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies.
    Kuo KL; Ho IL; Shi CS; Wu JT; Lin WC; Tsai YC; Chang HC; Chou CT; Hsu CH; Hsieh JT; Chang SC; Pu YS; Huang KH
    Cancer Lett; 2015 Jul; 363(2):127-36. PubMed ID: 25615422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.
    Hölscher AS; Schulz WA; Pinkerneil M; Niegisch G; Hoffmann MJ
    Clin Epigenetics; 2018; 10():1. PubMed ID: 29312470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-587 promotes cervical cancer by repressing interferon regulatory factor 6.
    Ren Y; Dong J; He P; Liang Y; Wu L; Wang J; Chu B
    J Gene Med; 2020 Nov; 22(11):e3257. PubMed ID: 32749750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of carbonic anhydrase IX as a potential therapeutic target in urothelial carcinoma.
    Todenhöfer T; Gibb EA; Seiler R; Kamyabi A; Hennenlotter J; McDonald P; Moskalev I; Stewart C; Gao J; Fazli L; Dedhar S; Stenzl A; Oo HZ; Black PC
    Urol Oncol; 2021 Aug; 39(8):498.e1-498.e11. PubMed ID: 34083096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lin28A promotes IRF6-regulated aerobic glycolysis in glioma cells by stabilizing SNHG14.
    Lu J; Liu X; Zheng J; Song J; Liu Y; Ruan X; Shen S; Shao L; Yang C; Wang D; Cai H; Cao S; Xue Y
    Cell Death Dis; 2020 Jun; 11(6):447. PubMed ID: 32527996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrostatic pressure enhances mitomycin C induced apoptosis in urothelial carcinoma cells.
    Chen SK; Chung CA; Cheng YC; Huang CJ; Ruaan RC; Chen WY; Li C; Tsao CW; Hu WW; Chien CC
    Urol Oncol; 2014 Jan; 32(1):26.e17-24. PubMed ID: 23403205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival.
    Jou YC; Tsai YS; Chen SY; Hsieh HY; Tsai HT; Tzai TS
    Virchows Arch; 2016 Jun; 468(6):733-40. PubMed ID: 27003158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation-Induced Inactivation of the IRF6 Gene as a Possible Early Event in Progression of Vulvar Squamous Cell Carcinoma Associated With Lichen Sclerosus.
    Rotondo JC; Borghi A; Selvatici R; Magri E; Bianchini E; Montinari E; Corazza M; Virgili A; Tognon M; Martini F
    JAMA Dermatol; 2016 Aug; 152(8):928-33. PubMed ID: 27223861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Therapeutic Potential of the Novel Isotype Specific HDAC Inhibitor 4SC-202 in Urothelial Carcinoma Cell Lines.
    Pinkerneil M; Hoffmann MJ; Kohlhof H; Schulz WA; Niegisch G
    Target Oncol; 2016 Dec; 11(6):783-798. PubMed ID: 27250763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression and regulatory role of ultraconserved long non-coding RNA uc.77 in lung cancer].
    Yu XW; Zhou JZ; Xu EW; Liu JY; Li MC; Wu JJ; Yang QY
    Zhonghua Zhong Liu Za Zhi; 2022 Oct; 44(10):1102-1111. PubMed ID: 36319456
    [No Abstract]   [Full Text] [Related]  

  • 16. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
    Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
    Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between methylation of interferon regulatory factor 6 gene promoter in renal tissues and overall survival of patients with Kidney renal clear cell carcinoma].
    Zhang J; Chen C; Wei Y; Chen L; Shao P; Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Feb; 41(2):150-156. PubMed ID: 38311552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma.
    Liang PI; Lai HY; Chan TC; Li WM; Hsing CH; Huang SK; Hsieh KL; Tseng WH; Chen TJ; Li WS; Chen HD; Kuo YH; Li CF
    BMC Cancer; 2023 Jun; 23(1):599. PubMed ID: 37380971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor γ (PPARγ) suppresses the proliferation and metastasis of patients with urothelial carcinoma after renal transplantation by inhibiting LEF1/β-catenin signaling.
    Shang D; Liu Y; Zhang J; Hu X
    Bioengineered; 2020 Dec; 11(1):1350-1367. PubMed ID: 33289586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma.
    Chan TC; Wu WJ; Li WM; Shiao MS; Shiue YL; Li CF
    Theranostics; 2020; 10(25):11775-11793. PubMed ID: 33052246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.